D-0464-2019 Class II Terminated

Recalled by Promise Pharmacy, LLC — Palm Harbor, FL

FDA drug recall D-0464-2019 was initiated by Promise Pharmacy, LLC on Dec 17, 2018 and is designated Class II. Reason for recall: Lack of sterility assurance. The recall status is terminated (terminated Mar 30, 2021). Affected quantity: 59 vials.

Recall Details

Product Type
Drugs
Report Date
Feb 20, 2019
Initiation Date
Dec 17, 2018
Termination Date
Mar 30, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
59 vials

Product Description

IGF-1-LR3, 3 mg injection, Rx Only, Promise Pharmacy Compounding Specialists 31818 US Hwy 19N, Palm Harbor, FL 34684

Reason for Recall

Lack of sterility assurance.

Distribution Pattern

Nationwide in the USA.

Code Information

Lot: 06282018@2 BUD: 12/25/2018

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0464-2019
openFDA file date
Nov 3, 2026
Loaded by RegDataLab
Nov 4, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0464-2019. Report a data issue: hello@regdatalab.com.